miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. (Q38849525)

7 September 2017

miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. (English)

1 reference

7 September 2017

1 reference

Gang Peng

1

1 reference

7 September 2017

Xianrui Yuan

2

1 reference

7 September 2017

Jian Yuan

3

1 reference

7 September 2017

Qing Liu

4

1 reference

7 September 2017

Minhui Dai

5

1 reference

7 September 2017

Chenfu Shen

6

1 reference

7 September 2017

Jianrong Ma

7

1 reference

7 September 2017

Yiwei Liao

8

1 reference

7 September 2017

Weixi Jiang

9

1 reference

7 September 2017

language of work or name

1 reference

26 July 2015

1 reference

Molecular and Cellular Biochemistry

7 September 2017

1 reference

7 September 2017

409

1 reference

7 September 2017

1-2

1 reference

7 September 2017

103-111

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-015-2516-x

7 September 2017

0 references

cites work

The molecular and genetic basis of neurological tumours

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

The miR-183/96/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

microRNAs are biomarkers of oncogenic human papillomavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Role of neurofilament light polypeptide in head and neck cancer chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

LATS2 is a tumor suppressor gene of malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Emerging strategies for treating brain metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2516-X

MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival

21 January 2018

1 reference

12 December 2020

Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

1 reference

12 December 2020

Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer

1 reference

12 December 2020

miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma

1 reference

12 December 2020

Primary brain tumours in adults

1 reference

12 December 2020

Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer

1 reference

12 December 2020

Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma

1 reference

12 December 2020

10.1007/S11010-015-2516-X

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference